Gadolinium texaphyrin-methotrexate conjugates. Towards improved cancer chemotherapeutic agents

Organic and Biomolecular Chemistry

Volumn 3, Issue 18, 2005, Pages 3290-3296

  Wei, Wen Hao ^a   Fountain, Mark ^a   Magda, Darren ^b   Wang, Zhong ^b   Lecane, Phil ^b   Mesfin, Mimi ^b   Miles, Dale ^b   Sessler, Jonathan L ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b PHARMACYCLICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INCUBATION; METHOTRXATE; MOTEXAFIN GADOLINIUM (MGD); TUMOR LOCALIZATION;

CELLS; ENZYMES; ESTERS; HYDROLYSIS; SYNTHESIS (CHEMICAL); TUMORS;

GADOLINIUM;

ANTINEOPLASTIC AGENT; GADOLINIUM TEXAPHYRIN; METALLOPORPHYRIN; METHOTREXATE;

ARTICLE; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; HUMAN; LUNG TUMOR; TIME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LUNG NEOPLASMS; METALLOPORPHYRINS; METHOTREXATE; MOLECULAR STRUCTURE; TIME FACTORS;

EID: 26444609658     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/b503664j     Document Type: Article

References (42)

1. J. H. Goldie and A. J. Coldman, Drug resistance in cancer: mechanisms and models, Cambridge University Press, Cambridge, UK, 1988.
2. N. M. Laing and K. D. Tew, in Encyclopedia of Cancer, ed. J. R. Bertino, Academic Press, San Diego, 1997, vol. 1, pp. 560-570.
3. S. A. Chowdhary and A. L. List, in Encyclopedia of Cancer, ed. J. R. Bertino, Academic Press, San Diego, 1997, vol. 1, pp. 610-620.
4. R. A. Messman and C. J. Allegra, in Cancer chemotherapy and biotherapy: principles and practice, ed. B. A. Chabner and D. L. Longo, Lippincott Williams & Wilkins, Philadelphia, 3rd edn., 2001, pp. 139-184.
5. R. V. J. Chari, Adv. Drug Delivery Rev., 1998, 31, 89-104.
6. A. Wunder, G. Stehle, H. H. Schrenk, G. Hartung, D. L. Heene, W. M. Borst and H. Sinn, Int. J. Cancer, 1998, 76, 884-890.
7. C. R. Gardener and J. Alexander, in Drug Targeting, ed. P. Buri and A. Gumma, Elsevier Science Publishers, Amsterdam, 1985, pp. 145-164.
8. N. Umemoto, Y. Kato, N. Endo, Y. Takeda and T. Hara, Int. J. Cancer, 1989, 43, 677-654.
9. A. Pasini and F. Zunino, Angew. Chem., Int. Eng. Ed., 1987, 26, 615-625.
10. C. K. Mathews, K. E. van Holde and K. G. Ahern, Biochemistry, 3rd edn., Benjamin Cummings, San Francisco, 2000, pp. 814-825.
11. I. W. Taylor, P. Slowiaczek, M. L. Friedlander and M. H. Tattersall, Cancer Res., 1985, 45, 978-982.
12. G. Hartung, G. Stehle, H. Sinn, A. Wunder, H. H. Schrenk, S. Heeger, M. Kranzle, L. Edler, E. Frei, H. H. Fiebig, D. L. Heene, W. Maier-Borst and W. Queisser, Clin. Cancer Res., 1999, 5, 753-759.
13. K. Riebeseel, E. Biedermann, R. Loeser, N. Breiter, R. Hanselmann, R. Muelhaupt, C. Unger and F. Kratz, Bioconjugate Chem., 2002, 13, 773-785.
14. C. Walker, J. M. Fraser, C. E. Walton, F. Widmer, C. L. Francis, Q. Yang, M. O'Sullivan, R. G. Whittaker and X. E. Wells, J. Drug Targeting, 2002, 10, 479-487.
15. R. Pignatello, S. Guccione, S. Forte, C. Di Giacomo, V. Sorrenti, L. Vicari, G. Uccello Barretta, F. Balzano and G. Puglisi, Bioorg. Med. Chem., 2004, 12, 2951-2964.
16. A. N. Vis, A. van der Gaast, B. W. G. van Rhijn, T. K. Catsburg, C. Schmidt and G. H. J. Mickisch, Cancer Chemother. Pharmacol., 2002, 49, 342-345.
17. J. R. Bertino, J. Clin. Pharmacol., 1990, 30, 291-295.
18. J. R. Piper, J. A. Montgomery, F. M. Sirotnak and P. L. Chello, J. Med. Chem., 1982, 25, 182-187.
19. I. D. Goldman, L. H. Matherly and G. Fabre, in Development of Target-Oriented Anticancer Drugs, ed. Y.-C. Cheng, B. Goz and B. A. Minkoff, Raven Press, New York, 1983, vol. 28, pp. 19-40.
20. Y. M. Rustum, in Development of Target-Oriented Anticancer Drugs, ed. Y.-C. Cheng, B. Goz and B. A. Minkoff, Raven Press, New York, 1983, vol. 28, pp. 119-128.
21. J. L. Sessler, T. Murai, V. Lynch and M. Cyr, J. Am. Chem. Soc., 1988, 110, 5586-5588.
22. J. L. Sessler, G. Hemmi, T. D. Mody, T. Murai, A. Burrell and S. W. Young, Acc. Chem. Res., 1994, 27, 43-50.
23. T. D. Mody, L. Fu and J. L. Sessler, in Progress in Inorganic Chemistry, ed. K. D. Karlin, John Wiley & Sons, Ltd., Chichester, 2001, vol. 49, pp. 551-598.
24. M. P. Mehta, P. Rodrigus, C. H. J. Terhaard, A. Rao, J. Suh, W. Roa, L. Souhami, A. Bezjak, M. Leibenhaut, R. Komaki, C. Schultz, R. Timmerman, W. Curran, J. Smith, S.-C. Phan, R. Miller, A. and M. Renschler, F., J. Clin. Oncol., 2003, 21, 2529-2536.
25. P. Carde, R. Timmerman, M. P. Mehta, C. D. Koprowski, J. Ford, R. B. Tishler, D. Miles, R. A. Miller and M. F. Renschler, J. Clin. Oncol., 2001, 19, 2074-2083.
26. S. W. Young, K. W. Woodburn, M. Wright, T. D. Mody, Q. Fan, J. L. Sessler, W. C. Dow and R. A. Miller, Photochem. Photobiol., 1996, 63, 892-897.
27. S. W. Young, F. Qing, A. Harriman, J. L. Sessler, W. C. Dow, T. D. Mody, G. W. Hemmi, Y. Hao and R. A. Miller, Proc. Nat. Acad. Sci. USA, 1996, 93, 6610-6615. Correction;
28. S. W. Young, F. Qing, A. Harriman, J. L. Sessler, W. C. Dow, T. D. Mody, G. W. Hemmi, Y. Hao and R. A. Miller, Proc. Nat. Acad. Sci. USA, 1999, 96, 2569.
29. D. Magda, M. Wright, R. A. Miller, J. L. Sessler and P. I. Sansom, J. Am. Chem. Soc., 1995, 117, 3629-3630.
30. R. Shimanovich, S. Hannah, V. Lynch, N. Gerasimchuk, T. D. Mody, D. Magda, J. Sessler and J. T. Groves, J. Am. Chem. Soc., 2001, 123, 3613-3614.
31. Drugs R&D, 2004, 5, 52-57.
32. M. P. Mehta, W. R. Shapiro, M. J. Glantz, R. A. Patchell, M. A. Weitzner, C. A. Meyers, C. J. Schultz, W. H. Roa, M. Leibenhout, J. Ford, W. Curran, S. Phan, J. A. Smith, R. A. Miller and M. F. Renschler, J. Clin. Oncol., 2002, 20, 3445-3453.
33. K. W. Woodburn, J. Pharm. Exp. Ther., 2001, 297, 888-894.
34. A. Ruck and H. Diddens, in The Fundamental Basis of Phototherapy, ed. H. J. G. Honigsman and A. Young, OEMF, Milano, 1996.
35. G. Lu, A. Slansky, P. Dobhal Mahabeer, L. Goswami, N., A. Graham, Y. Chen, M. Kanter Peter, R. Alberico, A., J. Spernyak, J. Morgan, R. Mazurchuk, R. Oseroff Allan, S. A. Grossman and K. Pandey Ravindra, Bioconjugate Chem., 2005, 16, 32-42.
36. A. Rosowsky and C.-S. Yu, J. Med. Chem., 1983, 26, 1448-1452.
37. M. Poe, J. Biol. Chem., 1977, 252, 3724-3729.
38. O. Mitsunobu, M. Wada and T. Sano, J. Am. Chem. Soc., 1972, 94, 679-680.
39. W.-H. Wei, T. Tomohiro, M. Kodaka and H. Okuno, J. Org. Chem., 2000, 65, 8979-8987.
40. A. T. Byrne, D. Magda, H. Nguyan, D. Miles, G. Boswell and R. A. Miller, Proc. Am. Assoc. Cancer Res., 2003, 44, 393.
41. J. L. Sessler, N. A. Tvermoes, D. M. Guldi, T. D. Mody and W. E. Allen, J. Phys. Chem. A, 1999, 103, 787-794.
42. T. Mosmann, J. Immunol. Methods, 1983, 65, 55-63.